Advertisement
Screener

AGIOS PHARMACEUTICALS, INC. (AGIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

AGIOS PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where AGIOS PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $372.98M went out.
  • Fiscal year ended 2025-12-31: from investing, $377.18M came in.
  • Fiscal year ended 2025-12-31: from financing, $8.68M came in.
  • Fiscal year ended 2025-12-31: change in cash, $12.88M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$372.98M$377.18M$8.68M*$12.88M
2024-12-31-$389.84M$363.44M$14.44M*-$11.96M
2023-12-31-$296.06M$239.57M$0.00$5.43M*-$51.05M
2022-12-31-$309.48M$243.26M$0.00$2.35M*-$63.87M
2021-12-31-$407.32M$1.25B-$802.49M$0.00$36.72M*$75.69M
2020-12-31-$290.76M$75.75M$0.00$0.00$261.52M*$46.51M
2019-12-31-$370.62M$91.44M$0.00$277.20M$12.41M*$10.43M
2018-12-31-$304.42M-$273.82M$516.21M$29.82M*-$32.22M
2017-12-31-$285.23M-$57.91M$270.25M$14.86M*-$58.03M
2016-12-31$38.56M-$119.35M$162.15M$7.63M*$88.99M
2015-12-31-$76.95M$128.31M$0.00$6.37M*$57.73M
2014-12-31-$59.35M-$333.34M$333.58M$1.58M*-$57.53M
2013-12-31-$56.40M-$87.22M$113.37M$10.51M*-$19.74M
2012-12-31-$49.55M$23.04M$142.00K-$26.36M
2011-12-31-$15.22M-$22.36M$57.00K$77.30M*$39.78M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$57.31M*$40.21M*$3.15M*
2026-03-31-$118.92M$141.31M$2.08M*$24.47M
2025-12-31-$96.21M*$90.08M*$2.56M*
2025-09-30-$88.15M*$95.56M*$4.43M*
2025-06-30-$77.12M*$78.97M*
2025-03-31-$111.49M$112.59M$1.62M*$2.72M
2024-12-31-$133.17M*-$49.16M*$4.84M*
2024-09-30-$84.22M*$250.79M*$2.64M*
2024-06-30-$72.59M*$37.24M*$1.10M*
2024-03-31-$99.87M$124.56M$5.86M*$30.56M
2023-12-31-$72.49M*$95.51M*$847.00K*
2023-09-30-$61.64M*$39.34M*$1.88M*
2023-06-30-$66.75M*$47.13M*
2023-03-31-$95.18M$57.60M$2.47M*-$35.12M
2022-12-31-$66.16M*$82.95M*
2022-09-30-$71.35M*$104.07M*$0.00*$1.19M*
2022-06-30-$74.23M*$82.81M*
2022-03-31-$97.73M-$26.57M$1.21M*-$123.10M
2021-12-31-$84.09M*-$94.42M*-$18.59M*
2021-09-30-$85.18M*-$232.73M*-$254.39M*$3.41M*
2021-06-30-$117.29M*-$298.15M*-$503.46M*
2021-03-31-$120.75M$1.87B$7.26M*$1.76B
2020-12-31-$49.40M*$71.40M*$582.00K*
2020-09-30-$68.21M*-$126.24M*$0.00*$3.45M*
2020-06-30-$67.80M*$22.46M*$252.10M*
2020-03-31-$105.36M$108.14M$5.38M*$8.16M
2019-12-31-$93.61M*-$184.77M*$277.20M*
2019-09-30-$85.59M*$80.38M*$0.00*$3.34M*
2019-06-30-$88.15M*$64.48M*$0.00*$3.81M*
2019-03-31-$103.27M$131.35M$0.00$4.86M*$32.94M
2018-12-31-$74.19M*-$12.80M*$0.00*$1.02M*-$85.98M*
2018-09-30-$63.84M*$2.77M*$0.00*$7.22M*-$53.84M*
2018-06-30-$67.39M*-$96.26M*$0.00*$9.51M*-$154.15M*
2018-03-31-$99.00M-$167.53M$516.21M$12.07M*$261.75M
2017-12-31-$74.45M*$41.85M*$0.00*$2.59M*-$30.02M*
2017-09-30-$77.72M*$66.42M*$0.00*$5.32M*-$5.98M*
2017-06-30-$58.99M*-$275.73M*$270.25M*$2.90M*-$61.56M*
2017-03-31-$74.07M$109.55M$0.00$4.05M*$39.52M
2016-12-31-$51.22M*-$77.52M*$0.00*$3.99M*-$124.75M*
2016-09-30-$49.03M*-$62.74M*$162.15M*$1.08M*$51.45M*
2016-06-30$157.82M*$35.74M*$1.45M*$195.01M*
2016-03-31-$19.01M-$14.83M$1.11M-$32.73M
2015-12-31-$30.53M*$20.96M*$1.29M*-$8.28M*
2015-09-30-$24.82M*$30.16M*$2.17M*$7.51M*
2015-06-30$3.98M*$32.21M*$1.09M*$37.28M*
2015-03-31-$25.59M$44.99M$2.03M$21.23M
2014-12-31-$7.78M*-$287.30M*$238.89M*-$56.02M*
2014-09-30-$23.47M*-$15.10M*$380.00K*-$38.20M*
2014-06-30-$1.07M*-$18.67M*$454.00K*$94.70M*$75.41M*
2014-03-31-$27.04M-$12.27M$582.00K-$38.72M
2013-12-31-$13.62M*-$20.41M*$50.00K*-$34.45M*
2013-09-30-$14.98M*-$80.72M*$28.00K*$124.20M*$28.53M*
2013-06-30-$15.82M*$9.88M*$47.00K*-$5.90M*
2013-03-31-$11.98M$4.04M$25.00K-$7.92M
2012-12-31-$11.63M*$19.84M*$54.00K*$8.26M*
2012-09-30-$11.40M*-$1.72M*-$13.09M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Zymeworks Inc. (ZYME)United States$1.902B-12.44
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55